MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watts, V. J.
Right arrow Articles by Neve, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watts, V. J.
Right arrow Articles by Neve, K. A.

0026-895X/97/020181-06$3.00/0
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
All rights of reproduction in any form reserved.
MOLECULAR PHARMACOLOGY 52:181-186 (1997).


ACCELERATED COMMUNICATION
Activation of Type II Adenylate Cyclase by D2 and D4 but Not D3 Dopamine Receptors

Val J. Watts and Kim A. Neve

Medical Research Service, Veterans Affairs Medical Center and Department of Behavioral Neuroscience, Oregon Health Sciences University, Portland, Oregon 97201

The D2-like dopamine receptors couple to a variety of signal transduction pathways, including inhibition of adenylate cyclase, mitogenesis, and activation of potassium channels. Although these effects are mediated via pertussis toxin-sensitive G proteins, Gi/o, it is likely that some of these effects are influenced by the release of G protein beta gamma subunits. Type II adenylate cyclase (ACII) is highly regulated by multiple biochemical stimuli, including protein kinase C, forskolin, G protein alpha  subunits, and G protein beta gamma subunits. The ability of beta gamma subunits to activate this enzyme in the presence of activated alpha s has been particularly well characterized. Although stimulation by beta gamma subunits has been described as conditional on the presence of activated alpha s, beta gamma subunits also potentiate ACII activity after activation of protein kinase C. We created stable cell lines expressing ACII and the D2L receptor, the D3 receptor, or the D4.4 receptor. Activation of D2L or D4.4 receptors, but not D3 receptors, potentiated beta -adrenergic receptor/Gs-stimulated activity of ACII, as measured by the intracellular accumulation of cAMP. Similarly, stimulation of D2L or D4.4 receptors potentiated phorbol ester-stimulated ACII activity in the absence of activated alpha s, whereas stimulation of D3 receptors did not. The effect of D2-like receptor stimulation was blocked by pretreatment with pertussis toxin and by inhibition of protein kinase C. We propose that activation of both D2L and D4.4 dopamine receptors potentiated phorbol-12-myristate-13-acetate-stimulated ACII activity through the release of beta gamma subunits from pertussis toxin-sensitive G proteins. In contrast, the lack of D3 receptor-mediated effects suggests that stimulation of D3 receptors does not result in an appreciable release of beta gamma subunits.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
C. H. Nguyen and V. J. Watts
Dexamethasone-Induced Ras Protein 1 Negatively Regulates Protein Kinase C {delta}: Implications for Adenylyl Cyclase 2 Signaling
Mol. Pharmacol., May 1, 2006; 69(5): 1763 - 1771.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Wu and J. J. Hablitz
Cooperative Activation of D1 and D2 Dopamine Receptors Enhances a Hyperpolarization-Activated Inward Current in Layer I Interneurons
J. Neurosci., July 6, 2005; 25(27): 6322 - 6328.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. A. Vortherms and V. J. Watts
Sensitization of Neuronal A2A Adenosine Receptors after Persistent D2 Dopamine Receptor Activation
J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 221 - 227.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Yao, P. Fan, Z. Jiang, W. S. Mailliard, A. S. Gordon, and I. Diamond
Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-{beta}{gamma} dimers
PNAS, November 25, 2003; 100(24): 14379 - 14384.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
F. W. Hopf, M. G. Cascini, A. S. Gordon, I. Diamond, and A. Bonci
Cooperative Activation of Dopamine D1 and D2 Receptors Increases Spike Firing of Nucleus Accumbens Neurons via G-Protein {beta}{gamma} Subunits
J. Neurosci., June 15, 2003; 23(12): 5079 - 5087.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. G. Cumbay and V. J. Watts
Heterologous Sensitization of Recombinant Adenylate Cyclases by Activation of D2 Dopamine Receptors
J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 1201 - 1209.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
D. Cussac, A. Newman-Tancredi, V. Pasteau, and M. J. Millan
Human Dopamine D3 Receptors Mediate Mitogen-Activated Protein Kinase Activation Via a Phosphatidylinositol 3-Kinase and an Atypical Protein Kinase C-Dependent Mechanism
Mol. Pharmacol., November 1, 1999; 56(5): 1025 - 1030.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
J. F. M. Vanhauwe, N. Fraeyman, B. J. B. Francken, W. H. M. L. Luyten, and J. E. Leysen
Comparison of the Ligand Binding and Signaling Properties of Human Dopamine D2 and D3 Receptors in Chinese Hamster Ovary Cells
J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 908 - 916.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
A. Newman-Tancredi, D. Cussac, V. Audinot, V. Pasteau, S. Gavaudan, and M. J. Millan
G Protein Activation by Human Dopamine D3 Receptors in High-Expressing Chinese Hamster Ovary Cells: A Guanosine-5'-O-(3-[35S]thio)-Triphosphate Binding and Antibody Study
Mol. Pharmacol., March 1, 1999; 55(3): 564 - 574.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
V. J. Watts, B. L. Wiens, M. G. Cumbay, M. N. Vu, R. L. Neve, and K. A. Neve
Selective Activation of Galpha o by D2L Dopamine Receptors in NS20Y Neuroblastoma Cells
J. Neurosci., November 1, 1998; 18(21): 8692 - 8699.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics